Coston McIsaac & Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $89K | Buy |
1,926
+10
| +0.5% | +$462 | 0.02% | 228 |
|
|
2025
Q1 | $116K | Sell |
1,916
-158
| -8% | -$9.57K | 0.03% | 173 |
|
|
2024
Q4 | $117K | Buy |
2,074
+233
| +13% | +$13.1K | 0.03% | 174 |
|
|
2024
Q3 | $95 | Hold |
1,841
| – | – | 0.03% | 191 |
|
|
2024
Q2 | $76K | Hold |
1,841
| – | – | 0.02% | 209 |
|
|
2024
Q1 | $99K | Hold |
1,841
| – | – | 0.03% | 179 |
|
|
2023
Q4 | $94K | Buy |
1,841
+22
| +1% | +$1.12K | 0.03% | 179 |
|
|
2023
Q3 | $105K | Sell |
1,819
-24
| -1% | -$1.39K | 0.04% | 159 |
|
|
2023
Q2 | $117K | Hold |
1,843
| – | – | 0.04% | 158 |
|
|
2023
Q1 | $127K | Hold |
1,843
| – | – | 0.05% | 151 |
|
|
2022
Q4 | $132 | Hold |
1,843
| – | – | 0.05% | 145 |
|
|
2022
Q3 | $131K | Sell |
1,843
-1
| -0.1% | -$71 | 0.06% | 128 |
|
|
2022
Q2 | $142K | Buy |
+1,844
| New | +$142K | 0.09% | 83 |
|